Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone
1 other identifier
interventional
39
1 country
1
Brief Summary
The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3 type-2-diabetes
Started Sep 2003
Longer than P75 for phase_3 type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 15, 2008
CompletedFirst Posted
Study publicly available on registry
August 19, 2008
CompletedAugust 19, 2008
August 1, 2008
3.5 years
August 15, 2008
August 18, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in body weight
24 weeks
Secondary Outcomes (1)
change in body composition
24 weeks
Study Arms (3)
1
NO INTERVENTIONusual care. Subjects had one 90 minute visit with registered dietitian
2.
ACTIVE COMPARATORStandard care. Subjects had 4 sessions with registered dietitian
3
ACTIVE COMPARATORIntensive care. subjects had 10 visits with registered dietitian
Interventions
lifestyle intervention includes meal planning, food preparation, food label reading, dining out, and physical activity counseling
Eligibility Criteria
You may qualify if:
- type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater
You may not qualify if:
- insulin treated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Takedacollaborator
Study Sites (1)
Northwestern Memorial Hospital Wellness Institute
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert F Kushner, MD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 15, 2008
First Posted
August 19, 2008
Study Start
September 1, 2003
Primary Completion
March 1, 2007
Study Completion
April 1, 2008
Last Updated
August 19, 2008
Record last verified: 2008-08